Keel Point, LLC Johnson & Johnson Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

A detailed history of Keel Point, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Keel Point, LLC holds 33,403 shares of JNJ stock, worth $5.05 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

33,403

Previous 33,144 0.78%

Holding current value

$5.05 Million

Previous $4.84 Million 11.75%

% of portfolio

0.46%

Previous 0.43%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $37,679 - $43,351	259 Added 0.78%	33,403 $5.41 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $259,017 - $283,057	1,794 Added 5.72%	33,144 $4.84 Million
Q1 2024 Apr 16, 2024	BUY	$155.22 - $162.74 $555,998 - $582,934	3,582 Added 12.9%	31,350 $4.96 Million
Q4 2023 Jan 30, 2024	SELL	$145.6 - $158.88 $63,627 - $69,430	-437 Reduced 1.55%	27,768 $4.35 Million
Q3 2023 Oct 26, 2023	SELL	$155.75 - $174.48 $139,863 - $156,683	-898 Reduced 3.09%	28,205 $4.39 Million
Q2 2023 Jul 12, 2023	BUY	$154.35 - $166.11 $248,966 - $267,935	1,613 Added 5.87%	29,103 $4.82 Million
Q1 2023 Apr 03, 2023	SELL	$151.05 - $180.26 $166,608 - $198,826	-1,103 Reduced 3.86%	27,490 $4.26 Million
Q4 2022 Jan 17, 2023	BUY	$160.2 - $179.79 $148,986 - $167,204	930 Added 3.36%	28,593 $0
Q3 2022 Oct 05, 2022	BUY	$161.33 - $179.52 $19,359 - $21,542	120 Added 0.44%	27,663 $4.52 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $185,681 - $205,355	-1,104 Reduced 3.85%	27,543 $4.7 Million
Q1 2022 Apr 27, 2022	SELL	$158.14 - $179.59 $2.57 Million - $2.92 Million	-16,266 Reduced 36.22%	28,647 $5.08 Million
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $180,411 - $200,172	1,157 Added 2.64%	44,913 $7.68 Million
Q3 2021 Nov 04, 2021	BUY	$161.5 - $179.47 $6.81 Million - $7.56 Million	42,149 Added 2622.84%	43,756 $7.07 Million
Q2 2021 Aug 06, 2021	SELL	$159.48 - $171.07 $6.46 Million - $6.93 Million	-40,514 Reduced 96.18%	1,607 $1.19 Million
Q2 2021 Aug 06, 2021	BUY	$159.48 - $171.07 $320,235 - $343,508	2,008 Added 5.01%	42,121 $6.94 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $73,320 - $81,659	479 Added 1.21%	40,113 $6.59 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $546,246 - $627,001	3,984 Added 11.18%	39,634 $6.24 Million
Q3 2020 Nov 18, 2020	BUY	$140.38 - $153.83 $3.1 Million - $3.4 Million	22,090 Added 162.91%	35,650 $5.31 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $50,107 - $60,493	-389 Reduced 2.79%	13,560 $1.91 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $139,591 - $193,411	1,256 Added 9.9%	13,949 $1.83 Million
Q4 2019 Feb 07, 2020	BUY	$127.5 - $146.44 $258,060 - $296,394	2,024 Added 18.97%	12,693 $1.85 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $55,096 - $61,688	434 Added 4.24%	10,669 $1.38 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $161,445 - $177,559	1,231 Added 13.67%	10,235 $1.43 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $150,612 - $167,468	1,198 Added 15.35%	9,004 $1.26 Million
Q4 2018 Feb 08, 2019	BUY	$122.84 - $147.84 $276,512 - $332,787	2,251 Added 40.52%	7,806 $1.01 Million
Q3 2018 Nov 07, 2018	BUY	$121.58 - $142.88 $86,808 - $102,016	714 Added 14.75%	5,555 $768,000
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $123,340 - $136,108	-1,033 Reduced 17.59%	4,841 $587,000
Q1 2018 May 07, 2018	SELL	$125.1 - $148.14 $22,392 - $26,517	-179 Reduced 2.96%	5,874 $753,000
Q4 2017 Feb 08, 2018	SELL	$131.22 - $143.62 $61,935 - $67,788	-472 Reduced 7.23%	6,053 $846,000
Q3 2017 Nov 09, 2017	SELL	$129.47 - $135.38 $27,836 - $29,106	-215 Reduced 3.19%	6,525 $848,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,740	6,740 $892,000

Others Institutions Holding JNJ

# of Institutions

4,301

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $395B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account